Kyverna Therapeutics, Inc. KYTX Return on equity

Return on equity at other companies

Bristol-Myers SquibbBMY

46.7%+17.8pp

Gilead SciencesGILD

-20.6%-53.8pp

Climb Bio, Inc.CLYM

-30.9%-10.3pp

Artiva Biotherapeutics, Inc.ARTV

-36.6%—

Iovance Biotherapeutics, Inc.IOVA

-40.4%-7.8pp

Allogene TherapeuticsALLO

-52.3%-5.7pp

FAQ

What is Kyverna Therapeutics, Inc.'s return on equity?

Kyverna Therapeutics, Inc. (KYTX) reported return on equity of -74.5% in Q1 2026.

How has Kyverna Therapeutics, Inc.'s return on equity changed year-over-year?

Kyverna Therapeutics, Inc.'s return on equity decreased by 50.0% year-over-year, from -49.7% to -74.5%.

What does return on equity mean?

Trailing-twelve-month net income divided by average shareholders' equity (average of the start and end of the trailing-twelve-month window). Measures the profit generated on each dollar of shareholder capital.